Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variant

被引:14
作者
Palácios, SA
Bittencourt, PL
Cançado, ELR
Farias, AQ
Massarollo, PCB
Mies, S
Kalil, J
Goldberg, AC
机构
[1] Univ Sao Paulo, Sch Med, Liver Unit, Inst Heart, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Lab Transplantat Immunol, Inst Heart, Sao Paulo, Brazil
来源
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION | 1999年 / 6卷 / 04期
关键词
transthyretin; familial amyloidotic polyneuropathy; Brazil;
D O I
10.3109/13506129909007342
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial amyloidotic polyneuropathy type I (FAP1) is an inherited systemic amyloidosis that is secondary to the deposition of transthyretin (TTR) variants in peripheral nerves and in certain visceral organs. More than 50 distinct mutations have already been described in the TTR gene. Yet, the most common mutation found worldwide is a substitution of valine for methionine in position 30 (Val30Met). Currently, the variants of TTR in Brazilian FAP1 patients remain largely unknown and the aim of this study was to analyze the frequency of the TTR Val30Met mutation in such Brazilian subjects. Methods: Thirty-two FAP1 patients belonging to 24 different families were studied for the presence of Val30Met variant by PCR-RFLP. Results: All Brazilian FAP1 subjects studied were positive for the TTR Val30Met variant. As expected, all of them were heterozygous for the mutation. Conclusion: TTR Val30Met mutation was the sole TTR variant found in Brazilian FAP1 patients in this cohort, and it was present even in those subjects without a clear history of Portuguese ancestry.
引用
收藏
页码:289 / 291
页数:3
相关论文
共 10 条
[1]  
BENSON MD, 1986, J RHEUMATOL, V13, P927
[2]   Progression of ventricular wall thickening after liver transplantation for familial amyloidosis [J].
Dubrey, SW ;
Davidoff, R ;
Skinner, M ;
Bergethon, P ;
Lewis, D ;
Falk, RH .
TRANSPLANTATION, 1997, 64 (01) :74-80
[3]  
GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298
[4]  
Monteiro E, 1998, HEPATO-GASTROENTEROL, V45, P1375
[5]   GENETIC ABNORMALITIES AND PATHOGENESIS OF FAMILIAL AMYLOIDOTIC POLYNEUROPATHY [J].
MURAKAMI, T ;
UCHINO, M ;
ANDO, M .
PATHOLOGY INTERNATIONAL, 1995, 45 (01) :1-9
[6]   TYPE-I FAMILIAL AMYLOIDOTIC POLYNEUROPATHY IN JAPAN [J].
NAKAZATO, M ;
SHIOMI, K ;
MIYAZATO, M ;
MATSUKURA, S .
INTERNAL MEDICINE, 1992, 31 (12) :1335-1338
[7]  
NICHOLS WC, 1990, CLIN GENET, V37, P44
[8]  
Saraiva M J, 1991, Neuromuscul Disord, V1, P3, DOI 10.1016/0960-8966(91)90037-S
[9]   Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (North of Portugal) [J].
Sousa, A ;
Coelho, T ;
Barros, J ;
Sequeiros, J .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 60 (06) :512-521
[10]   FAMILIAL AMYLOIDOTIC POLYNEUROPATHY IN SWEDEN - GEOGRAPHICAL-DISTRIBUTION, AGE-OF-ONSET, AND PREVALENCE [J].
SOUSA, A ;
ANDERSSON, R ;
DRUGGE, U ;
HOLMGREN, G ;
SANDGREN, O .
HUMAN HEREDITY, 1993, 43 (05) :288-294